Los Angeles Cancer Center Received $15 Million for Woman’s Health Center
On Mar. 26, 2005, The University of Southern California/Norris Comprehensive Cancer Center in Los Angeles announced a $15…
Diagnostics | FDA | Medicine | Pharmaceutical | Therapeutics
The Best Pharmaceuticals for Children Act improved safety and efficacy of patented and off-patent medicines for children
In 2002, the U.S. Congress passed the Best Pharmaceuticals for Children Act that improved safety and efficacy of…
Digital diagnostic technology developed with creation of AQUA (Automated Quantitative Analysis) at Yale Cancer Center
In 2002, digital diagnostic technology was developed with the creation of AQUA (Automated Quantitative Analysis) at Yale Cancer…
Red River Valley Research Corridor was established
In 2002, The Red River Valley Research Corridor was established by U.S. Senator Byron Dorgan. The corridor is…
Biotechnology | FDA | Medicine | Therapeutics
The acquisition of Immunex by Amgen for $16 billion was announced
On Dec. 17, 2001, the acquisition of Immunex by Amgen was announced for $16 billion in stock and…
Stanford researchers identified a novel gene family involved in asthma
On Nov. 19, 2001, researchers at Lucile Packard Children’s Hospital at Stanford announced they had identified a novel…
$2.5 million award from Jeld-Wen Foundation endowed OHSU Chair in Leukemia Research for Brian Druker
On Nov. 7, 2001, the Oregon Health Sciences University Foundation (OHSU) announced that the Klamath Falls-based JELD-WEN Foundation…
Dr. Leland Hartwell was awarded the 2001 Nobel Prize for Medicine ‘for discoveries of key regulators of the cell cycle’
On Oct. 8, 2001, Dr. Leland ‘Lee’ Hartwell from Fred Hutchinson Cancer Research Center was awarded the Nobel…
Biotechnology | Disease | FDA | Therapeutics
Genentech drug Cathflo Activase (alteplase) was approved
On Sept. 13, 2001, the Food and Drug Administration (FDA) announced it had approved Genentech’s request for it’s…
Biotechnology | Diagnostics | NIH | Oncology | Therapeutics
The National Cancer Institute launched the Consumer Advocates in Research and Related Activities program
On Sept. 10, 2001, the National Cancer Institute (NCI) launched the Consumer Advocates in Research and Related Activities…
National Cancer Institute and ACRIN launched first multicenter study to compare digital mammography
On Sept. 4. 2001, the National Cancer Institute (NCI) and the American College of Radiology Imaging Network launched…
The Alvin J Siteman Cancer Center was named a NCI Designated Cancer Center
In August 2001, the Alvin J. Siteman Cancer Center was named an National Cancer Institute (NCI) -Designated Cancer…
The Hutchinson Cancer Research Center played key role in largest-ever prostate-cancer prevention study
On Jul. 24, 2001, the largest-ever prostate cancer prevention study was launched by the National Cancer Institute and…
Oregon Health & Science University merged with Oregon Graduate Institute of Science and Technology
On Jul. 1, 2001, Governor John Kitzhaber signed legislation that expanded Oregon Health & Science University’s (OHSU) mission…
Louis Stokes Laboratories was dedicated
On Jun. 14, 2001, the National Institutes of Health (NIH) dedicated the Louis Stokes Laboratories (Building 50), a…
OMRF researchers found that BRCA1 and BRCA2 genes may predict breast cancer risk in women
On May 24, 2001, Dr. Eldon Jupe and a team of Oklahoma Medical Research Foundation (OMRF) researchers found…
The FDA approved Gleevec, developed by OHSU, for treatment of chronic myeloid leukemia
On May 10, 2001, the U.S. Food and Drug Administration (FDA) approved Gleevec, the world’s first targeted cancer…
Molecular biologist Shirley M. Tilghman was elected the first woman president of Princeton University
On May 5, 2001, molecular biologist Shirley M. Tilghman was elected the first woman president of Princeton University….
Genome BC awarded $136 million in funding
On Apr. 24, 2001, Genome Canada announced $136 million in funding to support 22 large-scale research projects and…
Biotechnology | FDA | HIV | Therapeutics
Genentech drug Valcyte (valganciclovir hydrochloride) was approved
On Mar. 29, 2001, the Food and Drug Administration (FDA) announced it had approved Genentech’s drug Valcyte (valganciclovir…
Seattle Genetics completed its IPO
On Mar. 7, 2001, Seattle Genetics launched its IPO and sold 7 million shares at $7 per share…
Biotechnology | Diagnostics | Genomics | NIH | Therapeutics
Working draft of the human genome sequence was published
In 2001, The February 16 issue of Science and February 15 issue of Nature contain the working draft…
The Seattle Cancer Care Alliance opened its doors
On Jan. 19, 2001, the Seattle Cancer Care Alliance outpatient clinic opened, the final phase in a more…
Corus Pharma was incorporated
On Jan. 12, 2001, Corus Pharma was incorporated as a private venture-backed development stage biopharmaceutical company focused on…
OHSU researchers produced the first genetically modified monkey
On Jan. 11, 2001, Oregon Health Sciences University (OHSU) researchers reported the production of the world’s first genetically…
Scientists developed the first transgenic cow clone for mastitis disease resistance
On Jan. 10, 2001, the U.S. Department of Agriculture and University of Vermont researchers produced a clone of…
The Vaccine and Gene Therapy Institute and Neurological Sciences Institute buildings opened on OHSU’s west campus
In 2001, the Oregon Health & Science University (OHSU) Vaccine and Gene Therapy Institute and Neurological Sciences Institute…
Vanderbilt-Ingram Cancer Center earned the NCI’s highest distinction as a Comprehensive Cancer Center
In 2001, the Vanderbilt-Ingram Cancer Center (VICC) earned the National Cancer Institute’s (NCI) highest distinction as a Comprehensive…
Holden Cancer Center awarded NCI Comprehensive Center designation
In 2001, the Holden Cancer Center at University of Iowa received National Cancer Institute (NCI) Comprehensive Center designation….
The Barshop Institute for Longevity and Aging Studies was established
In 2001, the Barshop Institute for Longevity and Aging Studies in the Texas Research Park at UT health…